Tenascin expression patterns and cells of monocyte lineage: Relationship in human gliomas

Modern Pathology

Volumn 13, Issue 1, 2000, Pages 56-67

  Kulla, Andres ^a   Liigant, Aive ^a   Piirsoo, Andres ^a   Rippin, Gerd ^b   Asser, Toomas ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Extracellular matrix; Glioma; Immunohistochemistry; Macrophages; Microglia; Tenascin

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN; TENASCIN;

ARTICLE; ASTROCYTOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CELL INFILTRATION; CELL LINEAGE; EXTRACELLULAR MATRIX; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MICROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL CULTURE;

EID: 0033972807     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880010     Document Type: Article

References (59)

1. Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB. National survey of patterns of care for brain tumour patients. J Neurosurg 1998;71:826-36.
2. Daumas-Duport C, Scheithauer B, O'Fallon I, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62:2152-65.
3. Kleihues P, Burger PC, Scheithauer BW. WHO international histological classification of tumours: histological typing of the tumours of the central nervous system. 2nd ed. Berlin: Springer-Verlag; 1993.
4. Koochekpour S, Merzak A, Pilkington GJ. Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer 1995;31A:375-80.
5. Giese A, Loo MA, Rief MD, Tran N, Berens ME. Substrates for astrocytoma invasion. Neurosurgery 1995;37:294-302.
6. Paulus W, Huettner C, Tonn JC. Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroids and early monolayer cultures. Int J Cancer 1994;58:841-6.
7. Giese A, Loo MA, Norman SA, Treasurywala S, Berens ME. Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J Cell Sci 1996;109: 2161-8.
8. Schenk S, Chiquet-Ehrismann R. Extracellular matrix proteins. Tenascins Meth Enzymol 1994;245:52-61.
9. Gulcher JR, Nies DE, Alexakos MJ, Ravikant NA, Sturgill ME, Marton LS, et al. Structure of the human hexabrachion (tenascin) gene. Proc Natl Acad Sci U S A 1991;88:9438-42.
10. Sriramarao P, Bourdon MA. A novel tenascin type III repeat is part of complex of tenascin alternative splices. Nucleic Acids Res 1993;21:163-8.
11. Friedlander DR, Hoffmann S, Edelmann GM. Functional mapping of cytotactin: proteolytic fragments active in cell-substrate adhesion. J Cell Biol 1988;107:2329-40.
12. Prieto AL, Edelmann GM, Crossin KL. Characterisation of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin/tenascin. J Cell Biol 1992;119:663-78.
13. Riou JF, Shi DL, Chiquet M. Expression of tenascin in response to neural induction in amphibian embryos. Development 1988;104:511-24.
14. Bronner-Fraser M. Distribution and function of tenascin during cranial neural crest development in chick. J Neurosci Res 1988;21:135-47.
15. Mackie EJ, Tucker RP, Halfter W, Chiquet-Ehrismann R, Epperlein HH. The distribution of tenascin coincides with pathways of neural crest migration. Development 1988;102: 237-50.
16. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988;107:2757-67.
17. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol 1991;22:636-43.
18. Bourdon MA, Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 1989; 108:1149-55.
19. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with fibronectin action. Cell 1988;53: 383-90.
20. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interaction during fetal development and oncogenesis. Cell 1986;47:131-9.
21. Lotz MM, Bursdal CA, Erickson HP, McClay DR. Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response. J Cell Biol 1989;109:1795-805.
22. Deryugina EI, Bourdon MA. Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 1996;109:643-52.
23. Ruegg CR, Chiquet-Ehrismann R, Alkay SS. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci U S A 1989;86:7437-41.
24. Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 1993;85:481-7.
25. Zagzag D, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostinovsky M, et al. Tenascin expression in astrocytomas correlates for angiogenesis. Cancer Res 1995;55:907-14.
26. Zagzag D, Friedlander DR, Dosik J, Chikramane S, Chan W, Greco MA, et al. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 1996;56:182-9.
27. Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS, et al. Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol 1998;16:2202-12.
28. Polverini PJ, Leibovich SJ. Induction of neovascularisation in vivo and endothelial proliferation in vitro by tumour associated macrophages. Lab Invest 1984;51:635-42.
29. Del Rio-Hortega P. Microglia. In: Penfield W, ed. Cytology and cellular pathology of the nervous system. Vol 2. New York: Hoeber; 1932. pp. 481-534.
30. Streit WJ, Graeber MB, Kreutzberg W. Functional plasticity of microglia: a review. Glia 1988;1:301-7.
31. Streit WJ, Kreutzberg GW. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 1988;268:248-63.
32. Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB. Immunohistochemical study of mononuclear cell infiltrates in malignant gliomas. Acta Neuropathol (Berlin) 1987;74: 269-77.
33. Hulette CM, Downey BT, Burger PC. Macrophage markers in diagnostic neuropathology. Am J Surg Pathol 1992;16:493-9.
34. Sunderkötter C, Steinbrink K, Goebler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol 1994:55:410-22.
35. Smith GM, Hale H. Macrophage/microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J Neurosci 1997;17:9624-33.
36. Gullberg D, Veiling T, Sjoberg G, Salmivirta K, Gaggero B, Tiger CF, et al. Tenascin expression correlates with macrophage invasion in Duchenne muscular dystrophy and myositis. Neuromuscul Disord 1997;7:39-54.
37. Shi ZR, Itzkowitz SH, Kim YS. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 1988;36:317-22.
38. Boon ME, Kok LP. Microwave cookbook of pathology: the art of microscopic visualisation. Leiden: Coulomb Press Leyden; 1987.
39. Chan AS, Leung SY, Wong MP, Yuen ST, Cheung N, Fan YW, et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma and ependymoma. Am J Surg Pathol 1988; 22:816-26.
40. Plate KH, Breier G, Millaeur B, Ullrich A, Risau W. Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993;53:5822-7.
41. Stratmann R, Krieg M, Haas R, Plate K. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J Neuropathol Exp Neurol 1997;56:1242-52.
42. Knott JC, Mahesparan R, Garcia-Carbera I, Bolge Tysnes B, Edwardsen K, Ness GO, et al. Stimulation of extracellular matrix components in the normal brain by invading glioma cells. Int J Cancer 1998;75:864-72.
43. Levin V, Freeman M, Landahl H. The permeability characteristic of brain adjacent to intracerebral rat tumors. Arch Neurol 1975;32:785-91.
44. Schiffer D, Chiò A, Giordana MT, Mauro A, Migheli A, Vigliani MC. The vascular response to tumor infiltration in malignant gliomas: morphometric and reconstruction study. Acta Neuropathol (Berl) 1989;77:369-78.
45. Schiffer D, Giordana MT, Germano I, Mauro A. Anaplasia and heterogeneity of GFAP expression in gliomas. Tumori 1986;72:163-70.
46. Kunz J, Gottschalk I, Jänisch W, Schulz W. Zellproliferation und expression des säuren gliafaserproteins (GFAP) in hirntumoren. Acta Histochem 1986;80:53-61.
47. Castellani P, Sir A, Zardi L, Barbanera A, Dorcaratto A, Viale G. Distribution of tenascin in human malignant gliomas is not related to cell proliferation. I Neurol Neurosurg Psychiatry 1997;62:290-1.
48. Hitchcock ER, Morris CS. Mononuclear cell infiltration in central portions of human astrocytomas. J Neurosurg 1988; 68:432-7.
49. Morris CS, Esiri MM. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 1. Gliomas. J Neurol Sci 1991; 101:57-85.
50. Roggendorf W, Strupp S, Paulus W. Distribution and characterisation of microglia/macrophages in human brain tumors. Acta Neuropathol (Berlin) 1996;92:288-93.
51. Judware R, Culp L. Extracellular matrix and matrix receptors: alteration during tumor progression. In: Bertino JR, ed. Encyclopedia of cancer. Vol 1. San Diego: Academic Press; 1997. pp. 660-79.
52. Brooks WH, Markesbery WR, Gupta GD, Roszman TL. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 1978;4:219-24.
53. Rossi ML, Jones NR, Candy E, Nicoll JA, Compton JS, Hughes JT, et al. The mononuclear cell infiltrate compared with survival in high grade astrocytomas. Acta Neuropathol 1989; 78:189-93.
54. Gately CL, Muul LM, Greenwood MA, Papazoglou S, Dick SJ, Kornlith PL, et al. In vitro studies on the cell-mediated immune response to human brain tumors. J Immunol 1984; 133:3387-95.
55. Roszmann T, Elliott L, Brooks W. Modulation of T-cell function by gliomas. Immunol Today 1991;12:370-4.
56. Morioka T, Baba T, Black KL, Streit W. Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors. Neurosurgery 1992;30:891-6.
57. Morioka T, Baba T, Black KL, Streit WJ. Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma. Acta Neuropathol 1992;83:590-7.
58. Gundersen D, Tran-Thang C, Sordat B, Mourali F, Ruegg C. Plasmin-induced proteolysis of tenascin C: modulation by T lymphocyte derived urokinase type plasminogen activator and effect on T lymphocyte adhesion, activation and cell clustering. J Immunol 1997;158:1051-60.
59. Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak HF. Pathogenesis of tumor stroma generation: a critical role of leaky blood vessels and fibrin deposition. Biochem Biophys Acta 1989;948:305-26.